Plasma Exosomal Proteomics Identifies Differentially Expressed Proteins as Biomarkers for Acute Myocardial Infarction

Area of Science:

• Cardiovascular Biology
• Proteomics
• Exosome Biology

Background:

• Myocardial infarction (MI) remains a primary cause of mortality and hospitalization globally.
• Exosomes play critical roles in intercellular communication, influencing physiological and pathological processes.
• Understanding exosomal components offers insights into disease mechanisms and potential therapeutic strategies.

Purpose of the Study:

• To identify and characterize differentially expressed proteins (DEPs) within plasma exosomes of myocardial infarction (MI) patients.
• To discover novel exosomal protein biomarkers for the early detection and diagnosis of MI.
• To explore potential exosomal therapeutic targets for MI treatment.

Main Methods:

• Proteomics analysis was employed to identify exosomal DEPs in plasma from patients with ST-elevation MI (STEMI), non-ST-elevation MI (NSTEMI), unstable angina, and healthy controls.
• Parallel Reaction Monitoring (PRM) was used to validate a subset of identified DEPs in an independent patient cohort.
• Bioinformatics analysis was conducted to elucidate the molecular mechanisms associated with the validated exosomal DEPs.

Main Results:

• Proteomic analysis identified 406 exosomal DEPs in MI patients compared to controls.
• Seven exosomal DEPs (F13A1, TSPAN33, YWHAZ in STEMI; F13A1, TSPAN33, ITGA2B, GP9, GP5, PPIA in NSTEMI) were successfully validated.
• All validated DEPs were significantly down-regulated in MI patients compared to controls, exhibiting high sensitivity and specificity.

Conclusions:

• The study identified seven specific exosomal proteins as potential diagnostic biomarkers for MI.
• These validated exosomal DEPs may serve as novel therapeutic targets for MI.
• The findings provide valuable insights into the molecular mechanisms underlying MI pathogenesis.